A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

NCT02232230 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Castrate Refractory Metastatic Prostate Cancer (mCRPC)

Interventions

DRUG: Provenge

Sponsor

GenesisCare USA

Collaborators

[object Object]